行情

DARE

DARE

Dare Bioscience
NASDAQ

实时行情|Nasdaq Last Sale

0.8700
+0.0100
+1.16%
已收盘, 16:00 09/16 EDT
开盘
0.8700
昨收
0.8600
最高
0.8822
最低
0.8301
成交量
3.80万
成交额
--
52周最高
3.250
52周最低
0.6000
市值
1,451.46万
市盈率(TTM)
-0.8348
分时
5日
1月
3月
1年
5年

分析师评级

3位分析师的综合评级

买入

免责声明:分析师观点仅供投资者决策参考,不构成任何买卖投资建议。

EPS

DARE 新闻

  • 亚马逊被曝“做手脚”推销其高利润率产品
  • 澎湃新闻.3小时前
  • 美联储内部严重分歧或令未来政策前景更扑朔迷离
  • 汇通网.3小时前
  • 沙特准备动用家底 但“最后一道防线”可能面临失守
  • 汇通网.3小时前
  • 油价飙升或给美联储一个新的降息理由?
  • 汇通网.4小时前

更多

所属板块

生物技术和医学研究
+0.98%
制药与医学研究
-0.14%

热门股票

名称
价格
涨跌幅

DARE 简况

Dare Bioscience, Inc., formerly Cerulean Pharma Inc., is a healthcare company. The Company is focused on the development and commercialization of products in women’s reproductive health. Its lead product candidate is Ovaprene, a clinical stage, non-hormonal contraceptive ring. The Company is developing Ovaprene to provide protection over multiple weeks of use and require no intervention at the time of intercourse. Ovaprene has a custom intravaginal ring design, with a permeable mesh in the center of the ring that creates a partial barrier to sperm, and a mechanism to release locally acting spermiostatic agents through the ring. The combination of these two complementary approaches produces attractive contraceptive efficacy outcomes that are consistent with the effective barrier option, the diaphragm, and short-acting hormonal options, such as oral pill, patches and vaginal ring.
展开

Webull提供Dare Bioscience Inc的股票价格,实时市场报价,专业分析师评级,深度图表和免费的股票新闻,以帮助您做出投资决策。